| GTO ID | GTC3243 |
| Trial ID | NCT05621486 |
| Disease | Advanced Solid Tumor |
| Altered gene | BT-001 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | B4T2-001 |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | A Clinical Study to Evaluate B4T2-001 CAR T Cells in the Treatment of Advanced Solid Tumors |
| Year | 2022 |
| Country | China |
| Company sponsor | Shanghai East Hospital |
| Other ID(s) | B4T2-PRC-IIT-001 |
| Cohort 1 | |||||||||
|
|||||||||